MedTrace Logo

High-dose Accelerated Theta Burst Stimulation for the Treatment of Alcohol Addiction

NCT05738174 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2025-09-19

No results posted yet for this study

Summary

This is a two-arm randomized placebo-controlled trial in which 72 patients with alcohol addiction are treated with high-dose accelerated intermittent theta burst stimulation (TBS).

Conditions

  • Alcohol Dependence

Interventions

DEVICE

high-dose accelerated intermittent theta burst stimulation

1200 pulses of iTBS per session with five sessions per day applied at five days (Monday-Friday) with 120% resting motor threshold

DEVICE

sham high-dose accelerated intermittent theta burst stimulation

1200 pulses of iTBS per session with five sessions per day applied at five days (Monday-Friday) with 120% resting motor threshold with angled coil

Sponsors & Collaborators

  • Berthold Langguth, MD, Ph.D.

    lead OTHER

Principal Investigators

  • Berthold Langguth · University Hospital of Regensburg, Department of Psychiatry and Psychotherapy at the Bezirksklinikum

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2025-12-30
Completion
2026-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05738174 on ClinicalTrials.gov